Eli Lilly and Company – Corporate Sponsor #SEBIO2017
Southeast BIO is pleased to welcome Eli Lilly and Company as sponsor for the 7th Annual Corporate Partnering Day. Lilly is looking to partner within its core therapeutic areas of oncology, immunology, diabetes, neurodegeneration and pain. The company is also looking for breakthrough solutions in novel biologic pathways, adjacent disease areas and disruptive technologies. Lilly is dedicated to the discovery of new medicines through the relentless pursuit of innovation. As part of a collaboration with Lilly, organizations could gain access to Lilly’s discovery and development teams with...
Read More16 Bioscience Companies Awarded $1 Million in State Grants
RESEARCH TRIANGLE PARK, N.C. – Sixteen life science companies throughout North Carolina have received just over $1 million in grants from a state program to support their development of new technologies and products. They are among 32 technology-oriented companies in total that received $1.9 million in funding from the One NC Small Business Program, administered by the N.C. Department of Commerce’s Office of Science, Technology & Innovation. “These grants are a critical tool to help spur new products and industries, increase the number of high-paying jobs across the state, and...
Read MoreSEBIO2017 Keynote Speaker
The Southeast BIO (SEBIO) Board of Directors is pleased to announce that Ned David, PhD, Co-Founder UNITY Biotechnology, will be our Keynote Speaker at the 19th Annual Investor & Partnering Forum in Pinehurst, North Carolina. We hope so see you November 14-16, 2017.
Read MorePfizer to invest $100M in Sanford, N.C. gene therapy operation, add jobs
SANFORD, N.C. – Pharmaceutical giant Pfizer Inc. plans to invest $100 million in its Sanford operations as part of a push into gene therapy, officials said Monday. The effort builds on a technology developed at the University of North Carolina at Chapel Hill and will create 40 jobs in Sanford. “Pfizer is proud to further expand our presence in North Carolina, particularly as we build our leadership in gene therapy,” Lynn Bottone, site leader at Pfizer Sanford, said in a statement. “We look forward to the next phase of this expansion as we build a clinical and...
Read MoreAGTC Announces U.S. FDA Orphan Drug Designation for Gene Therapy to Treat X-Linked Retinitis Pigment
GAINESVILLE, FL. & CAMBRIDGE, MA. – Applied Genetic Technologies Corporation (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted an orphan drug designation for its gene therapy product candidate for the treatment of X-linked retinitis pigmentosa (XLRP) caused by mutations in the RPGR gene. In June 2016 the company announced that the European Commission (EC) granted orphan medicinal product...
Read MoreSouth Carolina looks to grow life sciences industry
SPARTANBURG, S.C. – The state’s “burgeoning” $11.4 billion life sciences industry “has become as become a major driver in South Carolina’s economy,” according to the state Department of Commerce. A report released last week by the department shows the industry now has a footprint of 15,000 employees and 400 firms, many providing high-paying jobs in the Upstate. The report was prepared for the S.C. Biotechnology Industry Organization by the University of South Carolina’s Darla Moore School of Business. It is the first in-depth look at the state’s life sciences sector,...
Read More
Follow Us!